The global companion diagnostic tests in oncology market is anticipated to display phenomenal growth due to rising adoption of new tests, and shift from blockbuster drugs to personalized drugs and targeted therapies. Rising prevalence of cancer, increasing financial burden of cancer treatment, and increasing mortalities due to cancer are some of the major reasons for increasing demand for new and advanced ... Read more
